World Congress of Perinatal Medicine. San Francisco, USA, 1996/10/22.
The transmission of infections from the biologic mother to her offspring is popularly known as perinatal infection (PI).
It is not synonymous to infections during the perinatal or neonatal period.
Physicians should avoid focusing attention only on the TORCH agents in the evaluation of suspected PI.
Perinatal period begins from 28 weeks of gestation.
Would one consider in utero infections in the first or second trimester of pregnancy as PIs Developing countries have difficulty in collecting reliable and accurate data of Pls.
These data are useful to define the magnitude of the problems, to monitor the trends, to recognise the mode of spread, and to find a solution of Pls.
Most Pls are asymptomatic and diagnosis is extremely difficult.
Developing countries need rapid, easy-to-operate, simple, and cheap diagnostic tools urgently.
Access to health care in the remote city is limited.
Newer drugs are too expensive and very few patients can benefit from these.
Each developing country should prioritise its PI problems and tackle those that have serious public health problems and socio-economic impact.
Most developing countries should focus on HIV (human immunodeficiency virus) and HBV (hepatitis B virus) infections.
Other countries where ophthalmia, malaria or tuberculosis are prevalent or endemic, should focus on these.
Developing countries are more willing to allocate the budget for prevention of diseases than for treatment. (...)
Mots-clés Pascal : Infection, Périnatal, Transmission, Transmission mère enfant, Virus immunodéficience humaine, Lentivirus, Retroviridae, Virus, Virus hépatite B, Orthohepadnavirus, Hepadnaviridae, Diagnostic, Prévention, Education santé, Nouveau né, Homme, Virose
Mots-clés Pascal anglais : Infection, Perinatal, Transmission, Mother to child transmission, Human immunodeficiency virus, Lentivirus, Retroviridae, Virus, Hepatitis B virus, Orthohepadnavirus, Hepadnaviridae, Diagnosis, Prevention, Health education, Newborn, Human, Viral disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0386199
Code Inist : 002B05C02D. Création : 25/01/1999.